a drug (e.g., T-20) that inhibits the binding of HIV's envelope to a host cell's receptors.
Anti-HIV drug targeting the point where HIV locks on to an immune cell.
An experimental class of antiretroviral agents that binds to the envelope protein and blocks the structural changes necessary for the virus to fuse with the host CD4 cell . When the virus cannot penetrate the host cell membrane and infect the cell, HIV replication within that host cell is prevented.
A class of antiretroviral agents that binds to the envelope protein and blocks the structural changes necessary for the virus to fuse with the host CD4 cell. A recently approved drug in this class is enfuvirtide (T-20).
A group of HIV medications that prevent the HIV virus from penetrating and entering healthy CD4 cells, therefore, preventing HIV from replicating.
A fusion inhibitor is a class of antiretroviral drugs used to treat viral infections such as HIV. It works by blocking the virus from fusing with a cell's membrane to enter and infect the cell.